Mw-Med Sp. z o.o.

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Macular degeneration2 trials

Phase

• Phase 32 trials

Status

• Recruiting2 trials

Lead sponsor

• Hoffmann-La Roche1 trial
• King's College Hospital NHS Trust1 trial

Running trials

• Recruiting

  A Study of 36-Week Refill Exchanges of Port Delivery System (PDS) With Ranibizumab in nAMD

  NCT06847542· Phase 3· Hoffmann-La Roche· Source

• Recruiting

  Vitrectomy, Subretinal Tissue Plasminogen Activator (TPA) and Intravitreal Gas for Submacular Haemorrhage Secondary to Exudative (Wet) Age-related Macular Degeneration (TIGER).

  NCT04663750· Phase 3· King's College Hospital NHS Trust· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Macular degeneration2 recruiting